-
Product Insights
Deep Basin (Harvest Operations Corp.) AB
Deep Basin (Harvest Operations Corp.) AB is a producing field located in Alberta, Canada. It is being operated by Harvest Operations Corp. Empower your strategies with our Deep Basin (Harvest Operations Corp.) AB report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered...
-
Product Insights
Hay River (Harvest Operations Corp.) AB
Hay River (Harvest Operations Corp.) AB is a producing field located in Alberta, Canada. It is being operated by Harvest Operations Corp. Empower your strategies with our Hay River (Harvest Operations Corp.) AB report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered...
-
Thematic Analysis
NewRobotics in Agriculture – Thematic Intelligence
Robotics in Agriculture Thematic Report Overview Robotics will address challenges such as climate change and labor availability aiding the transformation in the future of agriculture. Robots will also support human workers by automating repetitive and strenuous tasks. Robots can also monitor crop health to optimize the application of agricultural inputs and assess readiness for harvesting, reducing food waste, and costs in the process. The Robotics in Agriculture thematic intelligence report gives you an in-depth insight into the robotics market and...
-
Product Insights
Rocky Mountain House (Harvest Operations Corp.) AB
Rocky Mountain House (Harvest Operations Corp.) AB is a producing field located in Alberta, Canada. It is being operated by Harvest Operations Corp. Empower your strategies with our Rocky Mountain House (Harvest Operations Corp.) AB report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed...
-
Company Insights
NewDeere & Company – Digital Transformation Strategies
Deere & Company Digital Transformation Strategies Report Overview Deere & Company (John Deere) has been focusing on using artificial intelligence, the Internet of Things (IoT), cloud-based mobile applications, big data, and drones to digitally transform its operations. The annual ICT spending of John Deere was estimated at $3.6 billion for 2023. A major share of this spending is earmarked for acquiring software, hardware, and ICT services from vendors. John Deere is a provider of advanced products and services. It manufactures...
-
Company Insights
Innovation and Patenting activity of Select Harvests Ltd Q4 2023
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of Select Harvests Ltd Q4 2023". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Idecabtagene Vicleucel in Multiple Myeloma (Kahler Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Idecabtagene Vicleucel in Multiple Myeloma (Kahler Disease) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Idecabtagene Vicleucel in Multiple Myeloma (Kahler Disease) Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Brexucabtagene Autoleucel in Burkitt Lymphoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Brexucabtagene Autoleucel in Burkitt Lymphoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Brexucabtagene Autoleucel in Burkitt Lymphoma Drug Details: Brexucabtagene Autoleucel (Tecartus) is...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Brexucabtagene Autoleucel in Hairy Cell Leukemia
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Brexucabtagene Autoleucel in Hairy Cell Leukemia report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Brexucabtagene Autoleucel in Hairy Cell Leukemia Drug Details: Brexucabtagene Autoleucel...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Brexucabtagene Autoleucel in Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Brexucabtagene Autoleucel in Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leukemia) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Brexucabtagene Autoleucel in Acute Lymphocytic Leukemia...